Place of death for people with HIV: A population-level comparison of eleven countries across three continents using death certificate data

Richard Harding, Stefano Marchetti, Bregje D. Onwuteaka-Philipsen, Donna M. Wilson, Miguel Ruiz-Ramos, Maria Cardenas-Turanzas, Yong Joo Rhee, Lucas Morin, Katherine Hunt, Joan Teno, Cecilia Hakanson, Dirk Houttekier, Luc Deliens, Joachim Cohen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: With over 1 million HIV-related deaths annually, quality end-of-life care remains a priority. Given strong public preference for home death, place of death is an important consideration for quality care. This 11 country study aimed to i) describe the number, proportion of all deaths, and demographics of HIV-related deaths; ii) identify place of death; iii) compare place of death to cancer patients iv), determine patient/health system factors associated with place of HIV-related death. Methods: In this retrospective analysis of death certification, data were extracted for the full population (ICD-10 codes B20-B24) for 1-year period: deceased's demographic characteristics, place of death, healthcare supply. Results: i) 19,739 deaths were attributed to HIV. The highest proportion (per 1000 deaths) was for Mexico (9.8%), and the lowest Sweden (0.2%). The majority of deaths were among men (75%), and those aged <50 (69.1%). ii) Hospital was most common place of death in all countries: from 56.6% in the Netherlands to 90.9% in South Korea. The least common places were hospice facility (3.3%-5.7%), nursing home (0%-17.6%) and home (5.9%-26.3%).iii) Age-standardised relative risks found those with HIV less likely to die at home and more likely to die in hospital compared with cancer patients, and in most countries more likely to die in a nursing home. iv) Multivariate analysis found that men were more likely to die at home in UK, Canada, USA and Mexico; a greater number of hospital beds reduced the likelihood of dying at home in Italy and Mexico; a higher number of GPs was associated with home death in Italy and Mexico. Conclusions: With increasing comorbidity among people ageing with HIV, it is essential that end-of-life preferences are established and met. Differences in place of death according to country and diagnosis demonstrate the importance of ensuring a "good death" for people with HIV, alongside efforts to optimise treatment.

Original languageEnglish (US)
Article number55
JournalBMC Infectious Diseases
Volume18
Issue number1
DOIs
StatePublished - Jan 25 2018
Externally publishedYes

Fingerprint

Death Certificates
HIV
Population
Mexico
International Classification of Diseases
Nursing Homes
Italy
Demography
Republic of Korea
Hospices
Terminal Care
Quality of Health Care
Certification

Keywords

  • Aids
  • End-of-life care
  • HIV
  • Mortality
  • Place of death

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Harding, R., Marchetti, S., Onwuteaka-Philipsen, B. D., Wilson, D. M., Ruiz-Ramos, M., Cardenas-Turanzas, M., ... Cohen, J. (2018). Place of death for people with HIV: A population-level comparison of eleven countries across three continents using death certificate data. BMC Infectious Diseases, 18(1), [55]. https://doi.org/10.1186/s12879-018-2951-x

Place of death for people with HIV : A population-level comparison of eleven countries across three continents using death certificate data. / Harding, Richard; Marchetti, Stefano; Onwuteaka-Philipsen, Bregje D.; Wilson, Donna M.; Ruiz-Ramos, Miguel; Cardenas-Turanzas, Maria; Rhee, Yong Joo; Morin, Lucas; Hunt, Katherine; Teno, Joan; Hakanson, Cecilia; Houttekier, Dirk; Deliens, Luc; Cohen, Joachim.

In: BMC Infectious Diseases, Vol. 18, No. 1, 55, 25.01.2018.

Research output: Contribution to journalArticle

Harding, R, Marchetti, S, Onwuteaka-Philipsen, BD, Wilson, DM, Ruiz-Ramos, M, Cardenas-Turanzas, M, Rhee, YJ, Morin, L, Hunt, K, Teno, J, Hakanson, C, Houttekier, D, Deliens, L & Cohen, J 2018, 'Place of death for people with HIV: A population-level comparison of eleven countries across three continents using death certificate data', BMC Infectious Diseases, vol. 18, no. 1, 55. https://doi.org/10.1186/s12879-018-2951-x
Harding, Richard ; Marchetti, Stefano ; Onwuteaka-Philipsen, Bregje D. ; Wilson, Donna M. ; Ruiz-Ramos, Miguel ; Cardenas-Turanzas, Maria ; Rhee, Yong Joo ; Morin, Lucas ; Hunt, Katherine ; Teno, Joan ; Hakanson, Cecilia ; Houttekier, Dirk ; Deliens, Luc ; Cohen, Joachim. / Place of death for people with HIV : A population-level comparison of eleven countries across three continents using death certificate data. In: BMC Infectious Diseases. 2018 ; Vol. 18, No. 1.
@article{833cfa63fab24746b9af4838f9bc9cdf,
title = "Place of death for people with HIV: A population-level comparison of eleven countries across three continents using death certificate data",
abstract = "Background: With over 1 million HIV-related deaths annually, quality end-of-life care remains a priority. Given strong public preference for home death, place of death is an important consideration for quality care. This 11 country study aimed to i) describe the number, proportion of all deaths, and demographics of HIV-related deaths; ii) identify place of death; iii) compare place of death to cancer patients iv), determine patient/health system factors associated with place of HIV-related death. Methods: In this retrospective analysis of death certification, data were extracted for the full population (ICD-10 codes B20-B24) for 1-year period: deceased's demographic characteristics, place of death, healthcare supply. Results: i) 19,739 deaths were attributed to HIV. The highest proportion (per 1000 deaths) was for Mexico (9.8{\%}), and the lowest Sweden (0.2{\%}). The majority of deaths were among men (75{\%}), and those aged <50 (69.1{\%}). ii) Hospital was most common place of death in all countries: from 56.6{\%} in the Netherlands to 90.9{\%} in South Korea. The least common places were hospice facility (3.3{\%}-5.7{\%}), nursing home (0{\%}-17.6{\%}) and home (5.9{\%}-26.3{\%}).iii) Age-standardised relative risks found those with HIV less likely to die at home and more likely to die in hospital compared with cancer patients, and in most countries more likely to die in a nursing home. iv) Multivariate analysis found that men were more likely to die at home in UK, Canada, USA and Mexico; a greater number of hospital beds reduced the likelihood of dying at home in Italy and Mexico; a higher number of GPs was associated with home death in Italy and Mexico. Conclusions: With increasing comorbidity among people ageing with HIV, it is essential that end-of-life preferences are established and met. Differences in place of death according to country and diagnosis demonstrate the importance of ensuring a {"}good death{"} for people with HIV, alongside efforts to optimise treatment.",
keywords = "Aids, End-of-life care, HIV, Mortality, Place of death",
author = "Richard Harding and Stefano Marchetti and Onwuteaka-Philipsen, {Bregje D.} and Wilson, {Donna M.} and Miguel Ruiz-Ramos and Maria Cardenas-Turanzas and Rhee, {Yong Joo} and Lucas Morin and Katherine Hunt and Joan Teno and Cecilia Hakanson and Dirk Houttekier and Luc Deliens and Joachim Cohen",
year = "2018",
month = "1",
day = "25",
doi = "10.1186/s12879-018-2951-x",
language = "English (US)",
volume = "18",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Place of death for people with HIV

T2 - A population-level comparison of eleven countries across three continents using death certificate data

AU - Harding, Richard

AU - Marchetti, Stefano

AU - Onwuteaka-Philipsen, Bregje D.

AU - Wilson, Donna M.

AU - Ruiz-Ramos, Miguel

AU - Cardenas-Turanzas, Maria

AU - Rhee, Yong Joo

AU - Morin, Lucas

AU - Hunt, Katherine

AU - Teno, Joan

AU - Hakanson, Cecilia

AU - Houttekier, Dirk

AU - Deliens, Luc

AU - Cohen, Joachim

PY - 2018/1/25

Y1 - 2018/1/25

N2 - Background: With over 1 million HIV-related deaths annually, quality end-of-life care remains a priority. Given strong public preference for home death, place of death is an important consideration for quality care. This 11 country study aimed to i) describe the number, proportion of all deaths, and demographics of HIV-related deaths; ii) identify place of death; iii) compare place of death to cancer patients iv), determine patient/health system factors associated with place of HIV-related death. Methods: In this retrospective analysis of death certification, data were extracted for the full population (ICD-10 codes B20-B24) for 1-year period: deceased's demographic characteristics, place of death, healthcare supply. Results: i) 19,739 deaths were attributed to HIV. The highest proportion (per 1000 deaths) was for Mexico (9.8%), and the lowest Sweden (0.2%). The majority of deaths were among men (75%), and those aged <50 (69.1%). ii) Hospital was most common place of death in all countries: from 56.6% in the Netherlands to 90.9% in South Korea. The least common places were hospice facility (3.3%-5.7%), nursing home (0%-17.6%) and home (5.9%-26.3%).iii) Age-standardised relative risks found those with HIV less likely to die at home and more likely to die in hospital compared with cancer patients, and in most countries more likely to die in a nursing home. iv) Multivariate analysis found that men were more likely to die at home in UK, Canada, USA and Mexico; a greater number of hospital beds reduced the likelihood of dying at home in Italy and Mexico; a higher number of GPs was associated with home death in Italy and Mexico. Conclusions: With increasing comorbidity among people ageing with HIV, it is essential that end-of-life preferences are established and met. Differences in place of death according to country and diagnosis demonstrate the importance of ensuring a "good death" for people with HIV, alongside efforts to optimise treatment.

AB - Background: With over 1 million HIV-related deaths annually, quality end-of-life care remains a priority. Given strong public preference for home death, place of death is an important consideration for quality care. This 11 country study aimed to i) describe the number, proportion of all deaths, and demographics of HIV-related deaths; ii) identify place of death; iii) compare place of death to cancer patients iv), determine patient/health system factors associated with place of HIV-related death. Methods: In this retrospective analysis of death certification, data were extracted for the full population (ICD-10 codes B20-B24) for 1-year period: deceased's demographic characteristics, place of death, healthcare supply. Results: i) 19,739 deaths were attributed to HIV. The highest proportion (per 1000 deaths) was for Mexico (9.8%), and the lowest Sweden (0.2%). The majority of deaths were among men (75%), and those aged <50 (69.1%). ii) Hospital was most common place of death in all countries: from 56.6% in the Netherlands to 90.9% in South Korea. The least common places were hospice facility (3.3%-5.7%), nursing home (0%-17.6%) and home (5.9%-26.3%).iii) Age-standardised relative risks found those with HIV less likely to die at home and more likely to die in hospital compared with cancer patients, and in most countries more likely to die in a nursing home. iv) Multivariate analysis found that men were more likely to die at home in UK, Canada, USA and Mexico; a greater number of hospital beds reduced the likelihood of dying at home in Italy and Mexico; a higher number of GPs was associated with home death in Italy and Mexico. Conclusions: With increasing comorbidity among people ageing with HIV, it is essential that end-of-life preferences are established and met. Differences in place of death according to country and diagnosis demonstrate the importance of ensuring a "good death" for people with HIV, alongside efforts to optimise treatment.

KW - Aids

KW - End-of-life care

KW - HIV

KW - Mortality

KW - Place of death

UR - http://www.scopus.com/inward/record.url?scp=85041455017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041455017&partnerID=8YFLogxK

U2 - 10.1186/s12879-018-2951-x

DO - 10.1186/s12879-018-2951-x

M3 - Article

C2 - 29370765

AN - SCOPUS:85041455017

VL - 18

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 55

ER -